Gaudium IVF & Women Health
add_icon

Gaudium IVF & Women Health

115.07
-1.67
(-1.43%)
Market Cap
837.56 Cr
PE Ratio
37.39
Volume
1,29,948.00
Day High - Low
119.50 - 113.40
52W High-Low
133.00 - 69.18
ann
There are new updates from the company22 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
837.56 Cr
EPS
3.12
PE Ratio
37.39
PB Ratio
5.70
Book Value
20.45
EBITDA
28.90
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
41.31
Debt to Equity
0.52
Forecast For
Actual

Company News

View All News
Caret
positive
NCLT New Delhi rejected an insolvency petition filed by Ramaa Capital against Gaudium IVF and Women Health Limited. The order dated May 15, 2026, was received on May 22, 2026.
neutral
Gaudium IVF board to meet on May 28 to consider audited financial results for FY26. Trading window closed from April 1.
neutral
Gaudium IVF and Women Health Limited responds to stock exchange queries about share price volatility, confirming no undisclosed price sensitive information exists and movement is purely market driven.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,630.10
#1 27,313.14
55.24
#1 2,762.90
8.15
#1 510
-14.98
59.07
1,227.10
12,626.46
74.90
814.20
16.36
182
37.25
56.66
518.95
10,759.27
57.30
1,645.85
22.25
185
74.66
55.53
465.85
7,414.72
45.91
829.04
18.06
156
125.46
61.28
607.50
6,095.70
76.38
998.85
29.74
62
22.09
57.71
562.55
1,824.84
22.80
742.70
16.70
78
-21.13
37.67
313.20
1,631.17
51.44
255.90
15.11
31
-13.89
63.70
1,206.10
1,035.16
17.75
111.60
28.72
48
65.93
41.78
470.80
920.09
#1 14.84
147.80
#1 134.60
19
#1 520.00
46.45
289.05
919.48
31.25
1,170.80
-18.47
-134
101.06
54.91

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
32.22 %
Net Income Growth
15.06 %
Cash Flow Change
153.49 %
ROE
-17.21 %
ROCE
-15.64 %
EBITDA Margin (Avg.)
-15.34 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
14
27
18
32
25
Expenses
9
18
13
18
18
EBITDA
6
9
5
14
7
Operating Profit %
39 %
33 %
29 %
43 %
27 %
Depreciation
1
0
1
1
1
Interest
0
0
1
1
1
Profit Before Tax
5
8
4
13
5
Tax
1
2
1
3
1
Net Profit
3
7
3
9
4
EPS in ₹
0.55
1.07
0.51
1.53
0.59

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
18
37
57
89
Fixed Assets
4
18
19
18
Current Assets
14
18
38
54
Capital Work in Progress
0
0
0
7
Investments
0
0
0
5
Other Assets
14
18
39
58
Total Equity & Liabilities
18
37
57
89
Current Liabilities
6
10
20
38
Non Current Liabilities
3
4
4
4
Total Equity
9
23
33
46
Reserve & Surplus
8
22
32
16
Share Capital
1
1
1
31

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
14
-3
-5
Investing Activities
-1
-16
-5
-15
Operating Activities
-1
24
3
9
Financing Activities
3
5
-1
2

Share Holding

% Holding
Jan 2025
Sept 2025
Feb 2026
Mar 2026
Promoter
99.98 %
99.98 %
71.29 %
71.29 %
FIIs
0.00 %
0.00 %
9.24 %
6.70 %
DIIs
0.00 %
0.00 %
5.11 %
2.62 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
13.52 %
14.67 %
Others
0.02 %
0.02 %
0.84 %
4.73 %
No of Share Holders
7
7
7
19,854

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Mar 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 Mar 2026 81.09 85.19

Announcements

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20152 hrs ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation22 hrs ago
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Standalone And Consolidated Financial Statements/Results Of The Company For The Quarter And Year Ended March 31 2026.22 hrs ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report7 days ago
Clarification On Price MovementApr 16, 2026
Clarification sought from Gaudium IVF and Women Health LtdApr 16, 2026
Intimation Regarding Change Of Corporate Identification Number Of The CompanyApr 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) ReguApr 07, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 01, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 ( "Listing Regulations")Apr 01, 2026
Closure of Trading WindowMar 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 19, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 18, 2026
Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Mar 12, 2026
Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 02, 2026
Intimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Mar 02, 2026
Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 02, 2026
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")Mar 02, 2026
Closure of Trading WindowMar 02, 2026
Listing of Equity Shares of Gaudium IVF and Women Health LtdFeb 27, 2026

Technical Indicators

RSI(14)
Neutral
55.61
ATR(14)
Less Volatile
7.38
STOCH(9,6)
Neutral
45.93
STOCH RSI(14)
Neutral
54.25
MACD(12,26)
Bearish
-1.31
ADX(14)
Weak Trend
19.88
UO(9)
Bearish
55.56
ROC(12)
Downtrend And Accelerating
-6.29
WillR(14)
Neutral
-32.32